Next Generation News and Research

RSS

Focusing on innovation for planetary health

The University of Bonn has once again recruited an exceptional talent: Ina Danquah has been appointed as the new Hertz-Chair "Innovation for Planetary Health" at the "University of Excellence Bonn".

17 Nov 2023

B-BiTE modality enhances anti-myeloma effects of clinically available antibodies

Multiple myeloma still appears to be an incurable hematological malignancy. One of the reasons is that myeloma cells can be heterogenous and acquire resistance after anti-myeloma treatment.

16 Nov 2023

American Heart Association commits to equity in cardiovascular health outcomes

Disparities in health care persist, with Hispanic and Black adults reporting less satisfaction with their interactions with physicians, leading to poorer quality of care and health outcomes.

16 Nov 2023

AI model predicts patient outcomes across multiple cancer types

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types.

16 Nov 2023

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced that it has joined the Alliance for mRNA Medicines (AMM), as a founding member.

From MaxCyte, Inc. 16 Nov 2023

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

A recent study in eClinicalMedicine found that fecal microbiota transplantation, combined with fruquintinib and tislelizumab, significantly improved survival rates in patients with microsatellite stable metastatic colorectal cancer, showing manageable safety and notable increases in progression-free and overall survival.

15 Nov 2023

Scientists develop an improved method to study Parkinson's disease in the lab

A recent study published in Progress in Neurobiology and led by researchers at the University of Arizona College of Medicine – Tucson has developed an improved method to study Parkinson's disease in the lab.

15 Nov 2023

Engineering approach reveals surprising macrophage phenotype with best tumor-targeting ability

Macrophages, a type of white blood cell that can destroy invading pathogens, have an innate ability to infiltrate tumor cells, making them a potentially important tool in treatments that use transplanted cells to fight disease, known as cell therapy.

15 Nov 2023

Stand Up To Cancer unveils new gastroesophageal cancer research teams and awards

Stand Up To Cancer (SU2C) today announced three Research Teams focused on bringing new therapies to clinical trials for the treatment of gastroesophageal cancer (GEC).

15 Nov 2023

New diagnostic workflow improves detection of 5q-spinal muscular atrophy

5q-spinal muscular atrophy (5q-SMA) is one of the more common types of spinal muscular atrophy (SMA) affecting around one in ten thousand individuals worldwide.

15 Nov 2023

Regenerative medicine takes leap forward with nasal cartilage-derived cartilage grafts

The Department of Biomedicine at the University of Basel and the University Hospital Basel, today announced that it delivered the first surgical procedure to treat Osteoarthritis (OA) in humans.

15 Nov 2023

New study identifies 4,749 key gene clusters that influence progression of 32 cancer types

Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed "prognostic modules," that significantly influence the progression of 32 different types of cancer.

13 Nov 2023

Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials

A prospective path for allogeneic cellular immunotherapies.

13 Nov 2023

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery

Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, today announced the launch of its ground-breaking service offering, OrganoidXploreTM.

13 Nov 2023

Howard Meyers commits $25 million to MD Anderson to establish Meyers Institute for Oncology Nursing

Howard Meyers, of Dallas, Texas, a member of The University of Texas MD Anderson Cancer Center Board of Visitors (BOV), has committed $25 million to The University of Texas MD Anderson Cancer Center to establish the Meyers Institute for Oncology Nursing.

10 Nov 2023

NCI grants $5 million to UTHealth Houston for cancer control research in Mexico and Latin America

A five-year, $5 million grant has been awarded by the National Cancer Institute (NCI) to the UTHealth Houston Institute for Implementation Science to support research and training in implementation science, with a focus on improving cancer control efforts in Mexico and Latin America.

10 Nov 2023

One in six patients with coronary artery disease found to have non-ischemic or dual cardiomyopathy

Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy discovered one out of every six patients with coronary artery disease had non-ischemic or dual cardiomyopathy.

10 Nov 2023

Beckman Coulter Life Sciences and Pillar Biosciences announce NGS application development pipeline for the Biomek NGeniuS System

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with next-generation sequencing (NGS) research solutions. Today the company announces a collaboration agreement with Pillar Biosciences, which develops and distributes IVD & RUO NGS testing solutions based on their proprietary SLIMamp® technology to help localize patient testing and optimize the selection of precision therapies for cancer patients.

From Beckman Coulter Life Sciences 10 Nov 2023

MD Anderson Cancer launches Institute for Data Science in to transform cancer care and research

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Data Science in Oncology (IDSO), which integrates the most advanced computational and data science approaches with the institution's extensive scientific and clinical expertise to significantly improve patient's lives by transforming cancer care and research.

9 Nov 2023

Human tissue model reveals diversity of bacterial strategies for urinary tract infections

The research, published today in Science Advances, is the first to use a sophisticated human tissue model to explore the interaction between host and pathogen for six common species that cause urinary tract infections.

8 Nov 2023

Next Generation News and Research

Focusing on innovation for planetary health

B-BiTE modality enhances anti-myeloma effects of clinically available antibodies

American Heart Association commits to equity in cardiovascular health outcomes

AI model predicts patient outcomes across multiple cancer types

MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

Scientists develop an improved method to study Parkinson's disease in the lab

Engineering approach reveals surprising macrophage phenotype with best tumor-targeting ability

Stand Up To Cancer unveils new gastroesophageal cancer research teams and awards

New diagnostic workflow improves detection of 5q-spinal muscular atrophy

Regenerative medicine takes leap forward with nasal cartilage-derived cartilage grafts

New study identifies 4,749 key gene clusters that influence progression of 32 cancer types

Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials

Crown Bioscience launches large-scale organoid panel screening platform for accelerated preclinical oncology drug discovery

Howard Meyers commits $25 million to MD Anderson to establish Meyers Institute for Oncology Nursing

NCI grants $5 million to UTHealth Houston for cancer control research in Mexico and Latin America

One in six patients with coronary artery disease found to have non-ischemic or dual cardiomyopathy

Beckman Coulter Life Sciences and Pillar Biosciences announce NGS application development pipeline for the Biomek NGeniuS System

MD Anderson Cancer launches Institute for Data Science in to transform cancer care and research

Human tissue model reveals diversity of bacterial strategies for urinary tract infections

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News